Mitsutoshi Uchida is a partner in the Corporate Department of Morrison Foerster Law Offices. He represents Japanese and non-Japanese clients in corporate transactions, including:
He also advises financial institutions and investment companies on Japanese regulatory matters.
Mitsutoshi is a bengoshi, admitted to practice in Japan, and a qualified lawyer in New York.
Astellas Pharma Inc.
Represented Astellas Pharma in its sale of 16 off-patent brand-name drugs for approximately $180 million (¥20.1 billion) to LTL Pharma Co., Ltd., a company founded by investment fund Unison Capital.
Aetos Capital Real Estate
Represented Aetos Capital Real Estate in its sale of Simplex Investment Advisors, a Japanese real estate asset management firm, to Hulic Co., Ltd. for approximately $1.3 billion.
Sekisui House Residential Investment Corporation
Represented Sekisui House Residential Investment in its approximately $2.3 billion merger with Sekisui House Reit, Inc., both public J-REITs sponsored by Sekisui House Ltd.
Charoen Pokphand Group
NEXON Co., Ltd.
Represented NEXON in its ¥98 billion global IPO, serving as issuer’s counsel.
Kenedix Retail REIT Corporation
Represented Kenedix Retail REIT in its ¥72 billion global IPO and follow-on global equity offerings, serving as underwriters’ counsel.
Japan Retail Fund Investment Corporation
Represented Japan Retail Fund Investment in multiple follow-on global equity offerings, serving as underwriters’ counsel.
Olympus Corporation
Represented Olympus in its ¥118 billion global equity offering, serving as underwriters’ counsel.
Shinsei Bank, Limited
Represented Shinsei Bank in its ¥75 billion global equity offering, serving as underwriters’ counsel.
Recommended in Japan: Banking and Finance
The Legal 500 Asia Pacific 2025
Highly Regarded in Japan: Capital Markets: Debt
IFLR1000 2024
Ranked in Japan: Capital Markets: Domestic (J-REITs)
Ranked in Japan: Capital Markets: Domestic (J-REITs)
Recommended for Japan: Capital Markets
Capital Markets Law